MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease

Y. Fang, R. Hardy, K. Yaffe, S. Little, C. Tanner, Y. Leng (San Francisco, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO).

Background: Sleep disturbances could be both prodromal marker and risk factor for PD. Studying early-life sleep trajectories and their connection to PD onset is critical for disentangling the role of sleep disturbances as prodromal or risk factors for PD, offering opportunities for early detection and intervention.

Method: We analyzed data from two ongoing online cohorts: Parkinson’s Progression Markers Initiative (PPMI)-Online (discovery cohort; initiated in 2021) and Fox Insight (FI; validation cohort; initiated in 2018). Participants self-reported sleep duration across different life stages (ages 18 to 80+ in PPMI-Online; ages 12 to 66+ in FI) with PD-related follow-ups every three months. Sleep trajectories were identified using latent class growth analysis (LCGA). Logistic and linear regression models were used to assess associations between sleep duration trajectories with PD risk and AAO, adjusting for demographics, lifestyle factors, and comorbidities.

Results: The combined sample included 5,660 individuals with PD and 10,245 without PD from PPMI-Online, and 1,929 PD participants from FI (age at sleep report 67.2±7.83 years; 9,735 (54.6%) female). LCGA identified nine sleep trajectories in PPMI-Online, stable in early adulthood but diverging in midlife (stable, increasing, decreasing). Midlife sleep reductions (6-7 to ≤5-6 hours/day: OR = 1.90, 95% CI 1.61-2.24, P < .001; 7-8 to ≤6-7 hours/day: OR = 1.64, 95% CI 1.40-1.91, P < .001) and consistent short sleep (<=6 hours/day throughout adulthood: OR = 1.41, 95% CI 1.19-1.67, P < .001) demonstrated increased PD risk. Short sleep in early adulthood or midlife also had earlier AAO. The strongest effects were seen in those with ≤6 hours/day throughout adulthood (PPMI-Online: β = -2.45 years, 95% CI -3.33 to -1.56, P <.001) and those with a continuous decrease since adolescence (FI: β = -4.23 years, 95% CI -5.52 to -2.93, P < .001). These effects were independent of RBD.

Conclusion: Self-reported short sleep in early adulthood and midlife sleep reductions are associated with increased PD risk and earlier AAO. Self-perceived midlife sleep reduction may be a marker for future PD. Persons with chronic short sleep may be candidates for preventive intervention.

Figure 1. Flow Diagram of Study Participants

Figure 1. Flow Diagram of Study Participants

Figure 2. Trajectories and PD Risk in PPMI-Online

Figure 2. Trajectories and PD Risk in PPMI-Online

Figure 3. Trajectories and PD AAO in PPMI-Online

Figure 3. Trajectories and PD AAO in PPMI-Online

Figure 4. Trajectories and PD AAO in FI

Figure 4. Trajectories and PD AAO in FI

Table 1. Demographic and Clinical Characteristics

Table 1. Demographic and Clinical Characteristics

To cite this abstract in AMA style:

Y. Fang, R. Hardy, K. Yaffe, S. Little, C. Tanner, Y. Leng. Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/life-course-sleep-duration-trajectories-and-risk-and-age-at-onset-of-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/life-course-sleep-duration-trajectories-and-risk-and-age-at-onset-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley